首页|期刊导航|中国脑血管病杂志|动脉瘤性蛛网膜下腔出血早期脑损伤相关分子标志物及可干预通路研究进展

动脉瘤性蛛网膜下腔出血早期脑损伤相关分子标志物及可干预通路研究进展OA

Advances in molecular biomarkers and targetable pathways in early brain injury after aneurysmal subarachnoid hemorrhage

中文摘要英文摘要

动脉瘤性蛛网膜下腔出血(aSAH)起病急、病情重,具有较高病死率和致残率.早期脑损伤(EBI)是影响aSAH患者急性期病情进展和远期预后的重要因素,其机制涉及血-脑屏障破坏、微循环障碍、脑水肿、神经炎症、血红蛋白降解产物毒性、铁稳态紊乱及程序性细胞死亡等.该文对aSAH后发生EBI的关键病理环节中可检测的相关分子标志物及具有干预潜力的通路进行了综述,以期为高危患者早期识别和治疗靶点选择提供参考.

Aneurysmal subarachnoid hemorrhage(aSAH)is an acute and severe neurosurgical emergency with high mortality and disability.Early brain injury(EBI)is an important factor affecting acute disease progression and long-term outcome after aSAH and its mechanisms involves blood-brain barrier disruption,microcirculatory dysfunction,brain edema,neuroinflammation,toxicity of hemoglobin degradation products,iron homeostasis disorder and regulated cell death.This review summarized the detectable molecular biomarkers and potentially targetable pathways in the key pathological processes of EBI after aSAH,aiming to provide a reference for the early identification of high-risk patients and the selection of therapeutic targets.

唐杰;孙军;徐佳明;魏衍鹏;易守明;张宾锐

325000 温州医科大学附属温州市中心医院神经外科325000 温州医科大学附属温州市中心医院神经外科325000 温州医科大学附属温州市中心医院神经外科325000 温州医科大学附属温州市中心医院神经外科325000 温州医科大学附属温州市中心医院神经外科325000 温州医科大学附属温州市中心医院神经外科

动脉瘤性蛛网膜下腔出血早期脑损伤分子标志物靶向治疗综述

Aneurysmal subarachnoid hemorrhageEarly brain injuryMolecular biomarkersTargeted therapyReview

《中国脑血管病杂志》 2026 (8)

549-559,11

10.3969/j.issn.1672-5921.2026.08.006

评论